ScopeManchester University NHS Foundation Trust
16 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
North West Genomic Laboratory Hub (Liverpool), Manchester Centre for Genomic Medicine, Liverpool Womens NHS Foundation Trust, Crown Street
Liverpool L8 7SS , United Kingdom
Liverpool L8 7SS , United Kingdom
Accreditation
Active
UKAS
9322
mft.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
9322
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Wythenshawe Hospital
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Wythenshawe
Test Capabilities (16)
| Standard Reference | Description | Category |
|---|---|---|
| Analysis of copy number changes for the purpose of clinical diagnosis and carrier/predictive testing in genes: Dystrophin, GJB1/PMP22/MPZ, LDLR CFTR SMN1/2 | Analysis of copy number changes for the purpose of clinical diagnosis and carrier/predictive testing in genes: Dystrophin, GJB1/PMP22/MPZ, LDLR CFTR SMN1/2 | Other |
| Chromosome analysis for : Prenatal Diagnosis | Chromosome analysis for: Developmental disorders | Other |
| DNA extraction and quantification | DNA extraction and quantification | Other |
| Detection of clinically relevant pharmacogenetic sequence variants in genes: CYP2C19 | Detection of clinically relevant pharmacogenetic sequence variants in genes: • DPYD • CYP2C19 | Other |
| Detection of sequence variants for the purpose of clinical diagnosis and predictive testing in gene: HFE (haemochromatosis) | Detection of sequence variants for the purpose of clinical diagnosis and predictive testing in gene: • HFE (haemochromatosis) | Other |
| Dosage Analysis by quantitative fluorescent PCR: Rapid Aneuploidy Screening, Spinal | Dosage Analysis by quantitative fluorescent PCR: Rapid Aneuploidy Screening, Spinal | Other |
| Haematological/Oncology disorders | Haematological/Oncology disorders | Other |
| Molecular and Cytogenetics examination activities for the purposes of clinical diagnosis: Chromosome profile analysis for detection of chromosomal imbalance as copy number gains or losses, and copy neutral changes | Molecular and Cytogenetics examination activities for the purposes of clinical diagnosis: Cytogenetics | Other |
| Muscular Atrophy | Muscular Atrophy | Other |
| Mutation detection for the purpose of clinical diagnosis, carrier detection and predictive testing in genes: Friedreich Ataxia, Myotonic Dystrophy1, Myotonic Dystrophy2 | Mutation detection for the purpose of clinical diagnosis, carrier detection and predictive testing in genes: Friedreich Ataxia, Myotonic Dystrophy1, Myotonic Dystrophy2 | Other |
| Mutation detection for the purpose of clinical diagnosis, confirmation, carrier detection and predictive testing in C9orf72-related disorders | Mutation detection for the purpose of clinical diagnosis, confirmation, carrier detection and predictive testing in C9orf72-related disorders | Other |
| Mutation detection for the purpose of clinical diagnosis, confirmation, carrier detection and predictive testing in disorders: Huntington Disease, Huntington Disease-like 2 Myotonic Dystrophy1, Myotonic Dystrophy2, Friedreich Ataxia, Oculopharyngeal Muscular Dystrophy, Spinal Bulbar Muscular Atrophy, Spinal Cerebellar Ataxia 1, 2, 3, 6, 7, 12 & 17, Dentatorubral-pallidoluysian atrophy, Maternal Cell Contamination | Mutation detection for the purpose of clinical diagnosis, confirmation, carrier detection and predictive testing in disorders: Huntington Disease, Huntington Disease-like 2 Myotonic Dystrophy1, Myotonic Dystrophy2, Friedreich Ataxia, Oculopharyngeal Muscular Dystrophy, Spinal Bulbar Muscular Atrophy, Spinal Cerebellar Ataxia 1, 2, 3, 6, 7, 12 & 17, Dentatorubral-pallidoluysian atrophy, Maternal Cell Contamination | Other |
| Mutation detection of sequence variants for the purpose of clinical diagnosis and quality assessment of PCR products: GJB6 (Connexin 30) | Mutation detection of sequence variants for the purpose of clinical diagnosis and quality assessment of PCR products: GJB6 (Connexin 30) | Other |
| Mutation detection, confirmation and carrier testing in disorders/ genes: Allele Specific PCR: Cystic Fibrosis | Mutation detection, confirmation and carrier testing in disorders/ genes: Allele Specific PCR: Cystic Fibrosis | Other |
| Mutation detection, confirmation and carrier/ predictive testing for the purpose of clinical diagnosis in genes: Detection of clinical relevant nucleic acid sequence for confirmation/cascade testing of NGS results or family studies related to validated methods ABCD1 (Adrenoleukodystrophy) Notch3 (Cadasil) LDLR/ APOB ex27/ PCSK9 ex7 (Familial Hypercholesterolaemia) FXN (Friedreich Ataxia) GJB2 (Hearing Loss) PMP22/MPZ/GJB1/MFN2 (HMSN/HNPP) PLA2G6 (Infantile Neuroaxonal Dystrophy) SGCE (Myoclonic Dystonia) MTM1 (Myotubular Myopathy) PANK2 (Pantothenate kinase- associated neurodegeneration) MECP2 (Rett Syndrome) FGFR3 exon 9 and 12 (Achondroplasia and Hypochondroplasia) CFTR (Cystic fibrosis transmembrane conductance regulator) | Mutation detection, confirmation and carrier/ predictive testing for the purpose of clinical diagnosis in genes: Detection of clinical relevant nucleic acid sequence for confirmation/cascade testing of NGS results or family studies related to validated methods ABCD1 (Adrenoleukodystrophy) Notch3 (Cadasil) LDLR/ APOB ex27/ PCSK9 ex7 (Familial Hypercholesterolaemia) FXN (Friedreich Ataxia) GJB2 (Hearing Loss) PMP22/MPZ/GJB1/MFN2 (HMSN/HNPP) PLA2G6 (Infantile Neuroaxonal Dystrophy) SGCE (Myoclonic Dystonia) MTM1 (Myotubular Myopathy) PANK2 (Pantothenate kinase- associated neurodegeneration) MECP2 (Rett Syndrome) FGFR3 exon 9 and 12 (Achondroplasia and Hypochondroplasia) CFTR (Cystic fibrosis transmembrane conductance regulator) | Other |
| Reproductive Medicine Disorders | Reproductive medicine disorders | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.